46:58

In this interview Dr. David Perlmutter talks with Dr. Deanna Minich about the many dimensions of melatonin that extend far beyond its classic use as a sleep aid. They explain that melatonin is a highly conserved molecule found in plants (phytomelatonin), the gut, skin, and virtually every cell, with gut enterochromaffin cells producing up to 400 × more melatonin than the pineal gland. The discussion covers melatonin’s powerful antioxidant capacity (a single molecule can scavenge up to ten reactive oxygen species) and its anti‑inflammatory activity, which phytomelatonin exhibits over six‑fold greater potency than synthetic melatonin because of accompanying plant compounds (beta‑carotene, chlorophyll, lutein, zeaxanthin). They compare melatonin (the “hormone of darkness”) with vitamin D (the “hormone of light”), noting that melatonin can bind the vitamin D receptor and amplifies many of its pleiotropic effects. The conversation moves to chronobiology: artificial light at night (LAN) suppresses pineal melatonin production, contributing to “darkness deficiency” and disrupting circadian rhythm, sleep, and downstream hormonal cascades (cortisol, testosterone, etc.). Age‑related decline in melatonin (sharp drop after age 20, plateauing around 60‑70) is linked to mitochondrial dysfunction, oxidative stress, and “inflamm‑aging.” They discuss dosing strategies, emphasizing that a physiological dose of ~0.3 mg outperforms a pharmacologic 3 mg dose, and that individual metabolism (CYP1A2 variability) can affect response. Safety considerations include rebound awakenings, potential receptor saturation, and the wide safety window (short‑term high doses used in COVID‑19 protocols). Synthetic melatonin is ~99 % of market products and may contain up to 13 adulterants (e.g., serotonin). Clinical applications explored include sleep, jet lag, immune support, cancer adjunct therapy, autoimmune disease, and short‑term COVID‑19 adjuncts. Finally, they look ahead to personalized chronobiology—using clock‑gene variants, wearable data, and glymphatic research—to tailor melatonin and other hormone interventions.

Chapters

More from David

0:46
youtube.com

Your Brain Cannot Afford Bad Sleep | Dr. David Perlmutter

1d ago
0:51
youtube.com

Could Red Light Therapy Help Parkinson’s? | Dr. David Perlmutter

4d ago
0:35
youtube.com

Why Successful People Still Feel Invisible | Dr. David Perlmutter

1w ago
1:01:37
youtube.com

Why Successful People Still Feel Invisible with John Miles

1w ago
0:55
youtube.com

Is Dementia Really Inevitable With Age? | Dr. David Perlmutter

1w ago
1:10
youtube.com

Can’t Drink Coffee? You’re Not Missing Out | Dr. David Perlmutter

1w ago
1:03
youtube.com

The Brain Health Risk We Don’t Talk About Enough | Dr. David Perlmutter

1w ago
0:54
youtube.com

Is It Too Late to Protect Your Brain?| Dr. David Perlmutter

2w ago
1:03
youtube.com

Newsflash: Alzheimer’s Is Not Caused by What We Thought | Dr. David Perlmutter

2w ago
0:51
youtube.com

What’s Really Hiding in Your Food? | Dr. David Perlmutter

3w ago
55:43
youtube.com

The Diet Linked to Up to 50% Lower Dementia Risk | Dr. Austin Perlmutter

3w ago
See all content